PreveCeutical Announces Appointment of Dr. Maher Khaled as Director of International Operations
26 févr. 2018 09h30 HE
|
PreveCeutical Medical Inc.
VANCOUVER, British Columbia, Feb. 26, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE: PREV)(OTCQB:PRVCF)(FSE:18H), announces the...
PreveCeutical Signs Research and Option Agreement with UniQuest Pty Limited for Development of Non-Addictive Analgesic Peptides
30 janv. 2018 09h30 HE
|
PreveCeutical Medical Inc.
VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announces that,...
ATI Physical Therapy: Healthcare Experts Discuss Alternatives to the Opioid Crisis
29 janv. 2018 17h14 HE
|
ATI Physical Therapy
Bolingbrook, Ill., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Experts from cross-sections of the U.S. healthcare industry met on January 26th in Chicago at the ATI Forum: Opioid Edition, Presented by ATI...
Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility
29 déc. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has completed a prestudy...
US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
28 nov. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release
20 sept. 2017 08h37 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced that it has filed an Abbreviated New Drug Application (ANDA) with...
NEW REPORT FROM GRANTMAKERS IN AGING EXPLORES IMPACT OF THE OPIOID EPIDEMIC ON RURAL AGING
24 août 2017 08h00 HE
|
Grantmakers In Aging
Washington, DC, Aug. 24, 2017 (GLOBE NEWSWIRE) -- The opioid crisis is a story of many types of pain, and how individuals, families, and entire communities – particularly small and rural ones – are...
Trevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain Medications
20 juin 2017 16h01 HE
|
Trevena Inc.
KING OF PRUSSIA, Pa., June 20, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced its recent participation in the “Cutting Edge Science Meeting Series to End the Opioid Crisis:...
BioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA
28 nov. 2016 06h00 HE
|
BioCorRx
ANAHEIM, CA, Nov. 28, 2016 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...
Issue Brief Explores the Many Facets of Opioid Abuse
14 sept. 2016 07h33 HE
|
The Center for Health Affairs
CLEVELAND, Sept. 14, 2016 (GLOBE NEWSWIRE) -- The Center for Health Affairs' August 2016 Issue Brief, A Growing Epidemic: Battling Opioid Abuse in Ohio, explores the many facets of the opioid abuse...